Back to search

Article

Population Pharmacokinetics of Rivaroxaban After Transjugular Intrahepatic Portosystemic Shunt

2025-11-03

Abstract excerpt

<title>Abstract</title> <p> Purpose Rivaroxaban, a new direct oral anticoagulant (DOAC), has demonstrated better efficacy and safety than traditional anticoagulants. Individualized anticoagulation is crucial in patients with a transjugular intrahepatic portosystemic shunt (TIPS) and portal vein hypercoagulability to avoid stent thrombosis. As TIPS shunts portal blood directly into the systemic circulation and m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6638dbf3-56fe-54aa-a300-54393a0d6afb
DOI
10.21203/rs.3.rs-7830914/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Population Pharmacokinetics of Rivaroxaban After Transjugular Intrahepatic Portosystemic ShuntDOI 10.21203/rs.3.rs-7830914/v1
Population pharmacokinetics and hemorrhagic risk analysis of rivaroxaban in Chinese elderly patients with non-valvular atrial fibrillationSemantic proximity
Effect of ABCB1 SNP polymorphisms on the plasma concentrations and clinical outcomes of rivaroxaban in Chinese NVAF patients: a population pharmacokinetic-based studySemantic proximity
Whole-Body Physiologically-Based Pharmacokinetic Modeling of GalNAc conjugated siRNAsSemantic proximity
Determinants of the over-anticoagulation response during warfarin initiation therapy in Asian patients based on population pharmacokinetic-pharmacodynamic analyses.Semantic proximity
A Physiological-Based Pharmacokinetic Model Embedded with a Target-Mediated Drug Disposition Mechanism Can Characterize Single-Dose Warfarin Pharmacokinetic Profiles in Subjects with Various CYP2C9 Genotypes under Different Cotreatments.Semantic proximity
Dose tailoring of dabigatran etexilate: obvious or excessive?Semantic proximity
Interindividual Variability of Apixaban Plasma Concentrations: Influence of Clinical and Genetic Factors in a Real-Life Cohort of Atrial Fibrillation Patients.Semantic proximity
Anesthetic techniques and perioperative outcomes in patients undergoing transjugular intrahepatic portosystemic shunt: a retrospective cohort studySemantic proximity
Pharmacokinetics and Dialytic Clearance of Apixaban During In Vitro Continuous Renal Replacement TherapySemantic proximity
Integrated PBPK-EO Modeling of Osimertinib: Predicting Pharmacokinetics, Intracranial EGFR Engagement, and Optimal Dosing Strategies in Clinical SettingsSemantic proximity
Population pharmacokinetic model to generate mechanistic insights in bile acid homeostasis and drug-induced cholestasisSemantic proximity
Population pharmacokinetics and pharmacogenomics of apixaban in Japanese adult patients with atrial fibrillation.Semantic proximity
Select a neighboring publication to make it the new centre.